glp 1 drugs semaglutide How GLP-1 medications are transforming diabetes and weight loss treatment Hims & Hers stock falls

Formulation strategies to improve oral peptide delivery

Note: Participants in the STEP-1 trial were patients with obesity

It's important to note that Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved for chronic weight management, while Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes management, though sometimes used off-label for weight loss

While these effects have proven helpful for some, its important to understand that the medication may impact more than weight alone

Both compounds interact with fundamental healing processes, but through different pathways that create additive or synergistic effects when combined